The Effects of Topical Antiglaucoma Drugs as Monotherapy on the Ocular Surface: A Prospective Study

Table 1

SCH I (mm) values and tear breakup time (TBUT) of the tear film (second) according to the groups during the beginning, 1st week, 1st month, 3rd month, 6th month, and 12th month controls.

	Beginning	1st week	1st month	3rd month	6th month	12th month	𝐹	𝑃
SCH I (mm)
Group 1	11.53 ± 4.45	13.73 ± 11.38	10.2 ± 5.48	11.67 ± 4.69	11.33 ± 4.97	11.27 ± 3.67	0.69	0.636
Group 2	12.86 ± 4.56	13.07 ± 3.52	12.93 ± 3.22	11.86 ± 2.18	11.29 ± 3.87	12 ± 3.01	0.81	0.547
Group 3	16.14 ± 7.03	13.71 ± 4.76	13.71 ± 5.47	13.14 ± 4.93	15.5 ± 4.97	14 ± 6.31	1.50	0.204
Group 4	10.93 ± 10.11	10.93 ± 8.53	9.79 ± 7.81	11.14 ± 8.38	11.29 ± 8.04	10.79 ± 8.19	0.47	0.796
Group 5	10.93 ± 3.17	9.43 ± 3.52	10.5 ± 3.23	8.79 ± 4.49	9.43 ± 3.88	9.14 ± 3.48	2.09	0.077
Group 6	11.86 ± 4.37	11.21 ± 5.58	11.21 ± 5.89	13.43 ± 4.65	12.5 ± 7.5	11.43 ± 7.15	0.75	0.592
𝐹	1.50	0.92	1.21	1.88	2.22	2.27
𝑃	0.199	0.474	0.313	0.106	0.061	0.055
BUT (sec)
Group 1	14.57 ± 3.63	11.67 ± 4.39	10.27 ± 3.56	11 ± 4.31	11.47 ± 3.8	12.07 ± 3.88	1.04	0.402
Group 2	14.5 ± 4.99	12.21 ± 3.58	12.36 ± 3.97	10.21 ± 2.94	10.71 ± 2.3	10.21 ± 3.04	1.96	0.096
Group 3	18 ± 4.15	18.86 ± 2.51	18 ± 4.66	18.5 ± 2.07	18.64 ± 4.09	19.71 ± 2.87	0.73	0.602
Group 4	16.5 ± 4.03	14.14 ± 4.09	14.36 ± 4.47	15.36 ± 4.34	16.5 ± 4.7	18.29 ± 4.25	7.06	0.001
Group 5	19.29 ± 2.13	16.57 ± 3.32	15.64 ± 2.93	16.43 ± 2.34	15.64 ± 3.63	16.21 ± 2.99	5.76	0.001
Group 6	16 ± 2.94	16.71 ± 2.16	17.36 ± 2.76	16.57 ± 4.52	17.64 ± 4.67	18.21 ± 5.37	1.04	0.403
𝐹	8.58	9.58	8.87	12.29	9.83	13.99
𝑃	0.051	0.0001	0.0001	0.0001	0.0001	0.0001